Assessment of the Psychosocial Status and Quality of Life of Liver Transplant Recipients


Darilmaz C., Unal A., YILMAZ S.

Transplantation Proceedings, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.transproceed.2026.05.029
  • Dergi Adı: Transplantation Proceedings
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO)
  • İnönü Üniversitesi Adresli: Evet

Özet

Background: To determine the prevalence and types of psychiatric disorders in liver transplant patients, identify sociodemographic and clinical risk factors, and assess their impact on quality of life compared with healthy individuals. Methods: Sixty liver transplant patients (≥1 year post-transplant) and 60 healthy volunteers were included in this cross-sectional study. Psychiatric disorders were assessed using the Structured Clinical Interview for DSM-5 (SCID-5/CV). Quality of life was measured with the Short Form-36 Health Survey (SF-36), depressive symptoms with Hamilton Depression Rating Scale (HAM-D), and anxiety with Beck Anxiety Inventory (BAI). Sociodemographic and clinical data were collected using a structured form. Nonparametric tests were applied. Results: At least 1 psychiatric disorder was present in 36.7% of patients. Anxiety related to another health condition (40.9%) and depression (27.3%) were most common. Psychiatric disorders were significantly associated with female gender and unmarried status, but not with clinical variables such as pre-transplant disease duration, waiting time, or post-transplant hospitalizations. Patients with psychiatric disorders had lower SF-36 scores in all subscales except physical functioning. Even patients without psychiatric disorders showed lower scores than healthy controls in some domains. Conclusion: Psychiatric disorders are common in liver transplant patients and negatively affect emotional, social, and mental aspects of quality of life. Post-transplant follow-up should include psychiatric assessment and psychosocial support, in addition to biomedical care.